Literature DB >> 19140852

Clinical practice guideline for the management of secondary hyperparathyroidism in chronic dialysis patients.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19140852     DOI： 10.1111/j.1744-9987.2008.00648.x

Source DB:  PubMed          Journal:  Ther Apher Dial        ISSN： 1744-9979            Impact factor:   1.762


× No keyword cloud information.
  62 in total

1.  Development of Severe Hyperparathyroidism Despite Short-Term Renal Replacement Therapy.

Authors:  Manabu Okada; Yoshihiro Tominaga; Takahisa Hiramitsu; Toshihiro Ichimori
Journal:  World J Surg       Date:  2018-02       Impact factor: 3.352

2.  Associations between the levels of sclerostin, phosphate, and fibroblast growth factor-23 and treatment with vitamin D in hemodialysis patients with low intact PTH level.

Authors:  Y Asamiya; A Yajima; S Shimizu; S Otsubo; K Tsuchiya; K Nitta
Journal:  Osteoporos Int       Date:  2014-11-04       Impact factor: 4.507

3.  Decreases in PTH in Japanese hemodialysis patients with secondary hyperparathyroidism: associations with changing practice patterns.

Authors:  Tadao Akizawa; Ryo Kido; Masafumi Fukagawa; Yoshihiro Onishi; Takuhiro Yamaguchi; Takeshi Hasegawa; Shunichi Fukuhara; Kiyoshi Kurokawa
Journal:  Clin J Am Soc Nephrol       Date:  2011-08-11       Impact factor: 8.237

4.  Low parathyroid hormone levels after parathyroidectomy reduce cardiovascular mortality in chronic hemodialysis patients.

Authors:  Noriyuki Iwamoto; Nodoka Sato; Masaya Nishida; Tetsuya Hashimoto; Hiroyuki Kobayashi; Satoru Yamazaki; Koji Okino; Masato Nishimura; Toru Takatani; Yu Okamoto; Tsuneyuki Nakanouchi; Masaki Koyama; Naoto Adachi; Kanji Ninomiya; Hisao Mabuchi; Kunitoshi Iseki
Journal:  Clin Exp Nephrol       Date:  2015-12-17       Impact factor: 2.801

Review 5.  Management of secondary hyperparathyroidism: how and why?

Authors:  Hirotaka Komaba; Takatoshi Kakuta; Masafumi Fukagawa
Journal:  Clin Exp Nephrol       Date:  2017-01-02       Impact factor: 2.801

6.  Number of enlarged parathyroid glands might be a predictor of cinacalcet response in advanced secondary hyperparathyroidism.

Authors:  Masahiro Yamamoto; Hiroaki Ogata; Masahide Mizobuchi; Noriyo Yoshida; Chiaki Kumata-Maeta; Fumihiko Koiwa; Kanji Shishido; Eriko Kinugasa
Journal:  Clin Exp Nephrol       Date:  2011-10-20       Impact factor: 2.801

7.  Impact of secondary hyperparathyroidism on ventricular mass regression after aortic valve replacement for aortic stenosis in hemodialysis-dependent patients.

Authors:  Yoshiyuki Takami; Kazuyoshi Tajima
Journal:  Heart Vessels       Date:  2014-04-24       Impact factor: 2.037

8.  Removal of autografted parathyroid tissue for recurrent renal hyperparathyroidism in hemodialysis patients.

Authors:  Yoshihiro Tominaga; Susumu Matsuoka; Nobuaki Uno; Toyonori Tsuzuki; Takahisa Hiramitsu; Norihiko Goto; Takaharu Nagasaka; Yoshihiko Watarai; Kazuharu Uchida
Journal:  World J Surg       Date:  2010-06       Impact factor: 3.352

9.  Parathyroidectomy and survival among Japanese hemodialysis patients with secondary hyperparathyroidism.

Authors:  Hirotaka Komaba; Masatomo Taniguchi; Atsushi Wada; Kunitoshi Iseki; Yoshiharu Tsubakihara; Masafumi Fukagawa
Journal:  Kidney Int       Date:  2015-03-18       Impact factor: 10.612

Review 10.  Research on kidney and mineral metabolism in Japan: past, present, and future.

Authors:  Masahide Mizobuchi; Hiroaki Ogata; Fumihiko Koiwa; Eriko Kinugasa; Tadao Akizawa
Journal:  Clin Exp Nephrol       Date:  2016-12-22       Impact factor: 2.801
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.